Relationship between ERCC1,Bcl-2 expression and cisplatin intervention in human lung adenocarcinoma cell lines
Ying Wan
Abstract
Ying Wan
Abstract
AIM:To study the relationship between the expressions of ERCC1,Bcl-2 and the effect of cisplatin in human lung adenocarcinoma cell lines,which suggested that the effects of ERCC1,Bcl-2 in cisplatin resistance effect.METHODS:A549 and A549/DDP cell lines were collected in the study,then the resistance of A549/DDP cells was measured by MTT assay.The expressions of ERCC1,Bcl-2 mRNA and protein after different concentrations' and different time' intervention were measured by immunocytohistology SABC assay and RT-PCR respectively.RESULTS:After treating with 10 μg/mL cisplatin for 12 h,the expressions of ERCC1,Bcl-2 mRNA and protein were increased in A549 cells;With the extension of time,the expressions of ERCC1 and Bcl-2 mRNA were increased gradually,they reached the peak levels in 72 h group.After treating with 5 μg/mL cisplatin for 24 h,the expressions of ERCC1,Bcl-2 mRNA and protein was increased in A549 cells.With the increase of concentration,the expressions of ERCC1 and Bcl-2 mRNA were increased gradually,they reached the highest levels in 20 μg/mL group.Compared with the paremtal cells,the expressions of ERCC1 and Bcl-2 mRNA and protein were increased significantly in A549/DDP cells.CONCLUSION:With increasing concentrations of cisplatin and action time,the expressions of ERCC1,Bcl-2 mRNA and protein are increased in A549 cells,then speculates that ERCC1 and Bcl-2 may be involved in cisplatin acquired resistance.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM:To study the relationship between the expressions of ERCC1,Bcl-2 and the effect of cisplatin in human lung adenocarcinoma cell lines,which suggested that the effects of ERCC1,Bcl-2 in cisplatin resistance effect.METHODS:A549 and A549/DDP cell lines were collected in the study,then the resistance of A549/DDP cells was measured by MTT assay.The expressions of ERCC1,Bcl-2 mRNA and protein after different concentrations' and different time' intervention were measured by immunocytohistology SABC assay and RT-PCR respectively.RESULTS:After treating with 10 μg/mL cisplatin for 12 h,the expressions of ERCC1,Bcl-2 mRNA and protein were increased in A549 cells;With the extension of time,the expressions of ERCC1 and Bcl-2 mRNA were increased gradually,they reached the peak levels in 72 h group.After treating with 5 μg/mL cisplatin for 24 h,the expressions of ERCC1,Bcl-2 mRNA and protein was increased in A549 cells.With the increase of concentration,the expressions of ERCC1 and Bcl-2 mRNA were increased gradually,they reached the highest levels in 20 μg/mL group.Compared with the paremtal cells,the expressions of ERCC1 and Bcl-2 mRNA and protein were increased significantly in A549/DDP cells.CONCLUSION:With increasing concentrations of cisplatin and action time,the expressions of ERCC1,Bcl-2 mRNA and protein are increased in A549 cells,then speculates that ERCC1 and Bcl-2 may be involved in cisplatin acquired resistance.
Key concepts: ERCC1, Cisplatin, A549 cell, Messenger RNA, Lung cancer, MTT assay, Adenocarcinoma, Chemistry